Explore
Validate
Learn
Western blot
ImmunoprecipitationAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN152381 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Estrogen Receptor 1 (ESR1) (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- C-Term
- Vial size
- 100 μL
- Storage
- Store at 4°C. Do not freeze.
- Handling
- Do not freeze.
Submitted references Lactoferrin-endothelin-1 axis contributes to the development and invasiveness of triple-negative breast cancer phenotypes.
Identification of a novel estrogen receptor-alpha variant and its upstream splicing regulator.
MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer.
The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling.
Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism.
Ha NH, Nair VS, Reddy DN, Mudvari P, Ohshiro K, Ghanta KS, Pakala SB, Li DQ, Costa L, Lipton A, Badwe RA, Fuqua S, Wallon M, Prendergast GC, Kumar R
Cancer research 2011 Dec 1;71(23):7259-69
Cancer research 2011 Dec 1;71(23):7259-69
Identification of a novel estrogen receptor-alpha variant and its upstream splicing regulator.
Ohshiro K, Mudvari P, Meng QC, Rayala SK, Sahin AA, Fuqua SA, Kumar R
Molecular endocrinology (Baltimore, Md.) 2010 May;24(5):914-22
Molecular endocrinology (Baltimore, Md.) 2010 May;24(5):914-22
MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer.
Di Leva G, Gasparini P, Piovan C, Ngankeu A, Garofalo M, Taccioli C, Iorio MV, Li M, Volinia S, Alder H, Nakamura T, Nuovo G, Liu Y, Nephew KP, Croce CM
Journal of the National Cancer Institute 2010 May 19;102(10):706-21
Journal of the National Cancer Institute 2010 May 19;102(10):706-21
The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling.
Popov VM, Zhou J, Shirley LA, Quong J, Yeow WS, Wright JA, Wu K, Rui H, Vadlamudi RK, Jiang J, Kumar R, Wang C, Pestell RG
Cancer research 2009 Jul 15;69(14):5752-60
Cancer research 2009 Jul 15;69(14):5752-60
Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism.
Zheng X, Chu F, Chou PM, Gallati C, Dier U, Mirkin BL, Mousa SA, Rebbaa A
American journal of physiology. Cell physiology 2009 Jan;296(1):C65-74
American journal of physiology. Cell physiology 2009 Jan;296(1):C65-74
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
